HAIFA, Israel--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT) today announced that it will present its unique placenta derived stem cell therapy approach and the company's strategy and vision for choosing the placenta as the source for cell therapy, at the Charles River Biotech Symposium on Biotechnology Derived Therapeutics in La Jolla, Calif.
